Short Summary
Merck has filed a post‑grant review petition challenging Halozyme’s U.S. Patent 12,077,791 covering modified PH20 hyaluronidase proteins. The petition asserts that the claims are overly broad and lack both written description and enablement under 35 U.S.C. §112(a). Merck seeks institution of the proceeding and cancellation of all claims.
Detailed Summary
In a petition for post‑grant review of U.S. Patent No. 12,077,791, Merck Sharp & Dohme LLC challenges Halozyme’s claims to modified human PH20 hyaluronidase polypeptides. The claims define a genus of proteins that may contain a substitution at position 309 and up to twenty additional substitutions, encompassing between 10^49 and 10^60 distinct variants. Merck argues that the patent’s specification provides no representative examples, structural “blaze marks,” or a workable method for producing the full scope, rendering the claims invalid for lack of written description and enablement under 35 U.S.C. §112(a). The petition requests that the PTAB institute the trial and invalidate all ten challenged claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Merck Sharp & Dohme LLC vs Halozyme, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Dyson Technology Limited et al.vsOmachron Intellectual Property Inc. et al.
Dyson and Omachron have settled the IPR challenge to U.S. Patent 10,327,607 and jointly moved to terminate the proceeding, requesting the settlement be kept confidential.
MICROSOFT CORPORATION et al.vsLiTL LLC
The PTAB denied institution of the IPR, finding that the Petitioner failed to demonstrate a reasonable likelihood of success in proving unpatentability. The claims related to graphical user interfaces (GUI) were challenged under 35 U.S.C. § 103(a).
VusionGroup SA et al.vsHanshow Technology Co., Ltd.
VusionGroup and Hanshow Technology entered a settlement that led to the termination of two inter partes review proceedings (IPR2024-00857 and IPR2024-00963). The Board granted the joint motion to terminate and partially protected the settlement documents as confidential.
Amazon.com, Inc. et al.vsNokia Technologies Oy
Amazon challenges Nokia's video coding patents (8,050,321) in an IPR petition, arguing that the claims are obvious over established standards like MPEG-1 and prior art references such as Kim and Yagasaki. The petitioner asserts that existing technologies render the core inventive concepts of the patent predictable.
Kohler Co.vsDelta Faucet Company et al.
Kohler Co. successfully petitioned the PTAB to institute an IPR against Delta Faucet Company et al., challenging claims related to illuminated showerheads. The Board found a reasonable likelihood of prevailing on key grounds, advancing the dispute to trial.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.